A B S T R A C T Five patients with herpes gestationis, a blistering disease of pregnancy, were studied immunologically. All had in vivo deposition of C3 in a linear band along the basement membrane zone of lesional and normnal-appearing skin, the location of early blister formation. Immunoglobulin deposition was more variable, though four patients had evidence of in vivo bound IgG at the same site. A circulating, complement binding herpes gestationis factor was demonstrated in the sera of four of the patients, its concentration unrelated to the activity of clinical disease. Characterization of this factor by sucrose gradient ultracentrifugation, specific absorption studies, and papain digestion indicates that it is an IgG. Evidence exists for involvement of both the classical and alternate complement pathways in vivo, though in vitro studies implicate the classical pathway as the primary route of complement activation. Three offspring were studied, none with clinical involvement; one slhowed in vivo deposition of C3 at the basement membrane zone of normal skin and a second showed the herpes gestationis factor in cord blood.
INTRODUCTION
Herpes gestationis (HG) ' is a rare, recurrent, intensely pruritic, subepidermal blistering disease which occurs during pregnancy or shortly thereafter. It had been considered a variant of erythema multiforme or dermatitis herpetiformis until Provost and Tomasi demonstrated HG to be a distinct disease (1) . They studied two patients with HG and found, on direct immunofluorescence Receized for puiblication 5 November 1975 and in revised form 3 February 1976. 1 Abbreviations used in this paper: BM, basement membrane; BP, bullous pemphigoid; EGTA, ethyleneglycoltetracetic acid; factor B, properdin factor B; FITC, fluorescein isothiocyanate; HG, herpes gestationis; IF, immunofluorescence; NFS, normal fresh serum; P, properdin; PBS, phosphate-buffered saline.
(IF), basement membrane (1BM) deposition of the third component of complement (C3) in the skin of both patients. Properdin and C5 were also detected at the BMI zone of the skin of one of their patients; Clq, immunoglobulins, or light chains were not found. In addition, a thermolabile, humoral factor called HG, which was thought not to be an immunoglobulin by partial characterization, was detected in the sera of both patients. Their studies indicated the activation of C3 by this HG factor via the alternate pathway, in the absence of demonstrable circulating antibodies.
Nine other patients have been studied and all had at least C3 bound in vivo at the BM zone (2) (3) (4) . Six of these patients had Ig deposition at the same site, and circulating BM\ antibodies were not demonstrable in their sera. Bushkell et al. (5) reported another HG patient whose lesions showed deposition of IgG, Clq, C3, and properdlin at the BMl zone on direct immunofluorescence. This patient, unlike the others, had a circulating antibody to BMI at a titer of 320.
We halve studied the sera and tissues of five patients with HG. In each patient there was a linear deposition of C3 in addition to other complement components at the B.-I zone of skin, which is the site of early and major pathology. The sera of all of these patients contained the HG factor, which deposited fresh C3 onto the BM of normal human substrate in an in vitro complement binding test. Our characterization of the HG factor defines it as an IgG and suggests that its in vitro activation of C3 is mainly via the classical pathway. This report will (a) detail this characterization of the HG factor, (b) describe the direct Papain digestion of HG sertum. 1 mg of papain was added to 1 ml of serum (patients 1, 3, and 4) containing 0.01 M cysteine and 0.002 M EDTA, and incubated for 8 h at 37°C. Chloromercuribenzoate was added to a final concentration of 0.001 M, and the serum was then dialyzed against PBS for 20 h. The cysteine, EDTA, and chloromercuribenzoate were added to another 1 ml of serum which was then dialyzed and used as a control. The complement binding assay and indirect IF technique were then performed with varying dilutions of the digested and nondigested sera.
Controls. Sera from 13 pregnant women in all stages of pregnancy were tested for circulating antibodies to the BM zone and for the complement binding factor by indirect IF. Normal and lesional skin from four women in the third trimester of pregnancy, all with widespread, pruritic dermatoses, were examined for in vivo bound Ig and C.
RESULTS
In vivo binding of Ig and C Ininunioglobulidn deposits. Linear IgG deposits at the basement membrane zone were seen in normal-appearing and lesional skin of patients 1 and 2, in normal-appearing skin of patient 3, and only in lesional skin of patient 5; they were not found in patient 4 . These deposits in the normal-appearing skin of patient 1 (Fig. 1) . Moreover, patient 1 had persistance of C3 for as long as 6 mo postpartum, both before and after taking Ortho-Novum 1/50. C3 was found in the normal-appearing skin of the 6-wk-old child of patient 2. Other complement components were seen less consistently. The alternate pathway components P and factor B were present in normal and lesional skin on all biopsies taken from patient 1 throughout her pregnancy and tip to 3 wk after delivery. They were also found in the normal skin of patient 2, taken 6 wk postpartum, and in lesional skin of patient 3. Factor B, but not P. was found in the lesional skin of patient 2, and P, but not factor B, in the normal skin of patient 3 (Table II) (Table  III) . It was not detected in the cord blood or serum from the baby of patient 1. The dilution at which each serum bound C3 from a 1: 10 dilution of fresh human serum did not vary throughout the pregnancy of patient 1 or 3 (Table III) . It was no longer detectable in the FIGURE 1 HG; complement binding. Intense C3 staining is present at the BM zone of an area adjacent to lesional skin (X 250). binding.
Immunopathology and Characterization of the Herpes Gestationis Factor

Comparison of HG and BP serum antibody titers and complement binding titers
The BP sera had complement binding titers ranging from 2 to 16 and antibody titers of greater than 160. This is in contrast to the findings in the HG sera where the complement binding titers were invariably higher than the circulating antibody titers.
Early complement component binding
When the sera of patients 1 or 4 were used as the first step in the complement binding technique, NFS (either undiluted or diluted 1: 10) as the second step, and FITC-labeled anti-Clq, or C4 as the third step, binding of both Clq and C4 could be demonstrated (Table IV) . When unlabeled goat anti-P or rabbit antifactor B was used as the third step and labeled sheep antirabbit Ig or rabbit antigoat Ig used as the fourth step, binding of neither could be demonstrated (Table   IV) .
The use of normal and C4-deficient guinea pig serum C3 in normal guinea pig serum (1: 10 dilution) was also bound by the HG factor in the complement binding test. However, when C4-deficient guinea pig serum (1: 10 dilution) was used as a source of complement, there was no C3 binding by the sera of patients 1 and 3. When the C4-deficient and normal guinea pig sera were mixed together (final dilution of each 1: 10) C3 was bound at the BAI zone of normal skin.
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In Vitro C3 Binding Chelation of serum with EDTA or EGTA When EDTA-treated sera of patients 1, 3, and 4 were used in the first step of the complement binding technique on normial human skin and a 1: 10 dilution of NFS in the second step, C3 was bound at the BM zone. If NFS treated with EDTA, EGTA, or EGTA-MIg++ was used in the second step, C3 was not bound. When the EGTAtreated NFS was reconstituted with CaCl2, there was C3 binding at the BM zone (Table V) .
Specific immunoabsorption studies
The supernatant fluids which remained after incubation of the sertum from patient 1 with normal goat serum, goat antilhuman IgG. or goat antihuman IgE contained 1,500 mg/dl, 300 mg/dl and 1,400 mg/dl of IgG respec- While there is solid evidence that HG factor is transferred across the placenta in most instances (patients 2 and 3), the cord and baby blood in case 1, where the highest titer of this factor was found, did not contain demonstrable levels; this observation is at present unexplained. The possibility that it was trapped within the placenta was explored, but increased placental IgG deposition could not be discerned over and above the high background levels of two normal placentas, and C3 could not be identified as specifically bound to the villous BM on direct IF.
The in vivo binding of early complement components necessary for the activation of the classical (Clq, C4) and alternate (P, factor B) complement pathways implicates both routes Nosologically, HG may be more closely related to BP than it is to either dermatitis herpetiformis or erythema multiforme. The immunopathology is similar in that IgG and C3 are bound in vivo at the BM zone of lesional and normal skin in both diseases. There are, however, distinct light and electron microscopic differences as well as differences in the ultrastructural localization of in vivo bound C3 in the two diseases (14) . Moreover, the complement binding ability of the anti-BM zone IgG in BP is found in lower titer than its demonstrable antibody activity; the converse is true in HG. The patient population at risk, provocative factors (e.g. oral contraceptives), and the universal tendency toward remission after and between pregnancies further serve to separate HG as a distinct entity.
